Return On Assets of Karyopharm Therapeutics Inc. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Karyopharm Therapeutics Inc. quarterly and annual Return On Assets in % history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • Karyopharm Therapeutics Inc. Return On Assets for the quarter ending 31 Dec 2025 was -179%, a 353% decline year-over-year.
  • Karyopharm Therapeutics Inc. annual Return On Assets for 2025 was -179%, a 353% decline from 2024.
  • Karyopharm Therapeutics Inc. annual Return On Assets for 2024 was -40%, a 22% increase from 2023.
  • Karyopharm Therapeutics Inc. annual Return On Assets for 2023 was -50%, a 13% increase from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Karyopharm Therapeutics Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -179% -140% -353% 01 Oct 2025 31 Dec 2025
Q3 2025 -101% -60% -145% 01 Jul 2025 30 Sep 2025
Q2 2025 -84% -46% -118% 01 Apr 2025 30 Jun 2025
Q1 2025 -36% +22% +38% 01 Jan 2025 31 Mar 2025
Q4 2024 -40% +11% +22% 01 Oct 2024 31 Dec 2024
Q3 2024 -41% +3.4% +7.6% 01 Jul 2024 30 Sep 2024
Q2 2024 -39% +8% +17% 01 Apr 2024 30 Jun 2024
Q1 2024 -58% -3.9% -7.1% 01 Jan 2024 31 Mar 2024
Q4 2023 -50% +7.5% +13% 01 Oct 2023 31 Dec 2023
Q3 2023 -45% -12% -38% 01 Jul 2023 30 Sep 2023
Q2 2023 -47% -9.4% -25% 01 Apr 2023 30 Jun 2023
Q1 2023 -54% -16% -42% 01 Jan 2023 31 Mar 2023
Q4 2022 -58% -14% -31% 01 Oct 2022 31 Dec 2022
Q3 2022 -32% +41% +56% 01 Jul 2022 30 Sep 2022
Q2 2022 -37% +31% +46% 01 Apr 2022 30 Jun 2022
Q1 2022 -38% +24% +38% 01 Jan 2022 31 Mar 2022
Q4 2021 -44% +10% +18% 01 Oct 2021 31 Dec 2021
Q3 2021 -73% -17% -30% 01 Jul 2021 30 Sep 2021
Q2 2021 -69% -14% -26% 01 Apr 2021 30 Jun 2021
Q1 2021 -62% -1.7% -2.9% 01 Jan 2021 31 Mar 2021
Q4 2020 -54% +17% +24% 01 Oct 2020 31 Dec 2020
Q3 2020 -56% +15% +21% 01 Jul 2020 30 Sep 2020
Q2 2020 -55% +25% +31% 01 Apr 2020 30 Jun 2020
Q1 2020 -60% +15% +20% 01 Jan 2020 31 Mar 2020
Q4 2019 -71% +2.6% +3.5% 01 Oct 2019 31 Dec 2019
Q3 2019 -72% +7.4% +9.4% 01 Jul 2019 30 Sep 2019
Q2 2019 -79% -3.6% -4.7% 01 Apr 2019 30 Jun 2019
Q1 2019 -75% +6.7% +8.3% 01 Jan 2019 31 Mar 2019
Q4 2018 -74% +1.3% +1.7% 01 Oct 2018 31 Dec 2018
Q3 2018 -79% -11% -16% 01 Jul 2018 30 Sep 2018
Q2 2018 -76% -13% -20% 01 Apr 2018 30 Jun 2018
Q1 2018 -81% -16% -25% 01 Jan 2018 31 Mar 2018
Q4 2017 -75% -15% -25% 01 Oct 2017 31 Dec 2017
Q3 2017 -68% -9.6% -16% 01 Jul 2017 30 Sep 2017
Q2 2017 -63% -6.1% -11% 01 Apr 2017 30 Jun 2017
Q1 2017 -65% -13% -24% 01 Jan 2017 31 Mar 2017
Q4 2016 -60% -13% -29% 01 Oct 2016 31 Dec 2016
Q3 2016 -59% -13% -29% 01 Jul 2016 30 Sep 2016
Q2 2016 -57% -16% -38% 01 Apr 2016 30 Jun 2016
Q1 2016 -53% -13% -32% 01 Jan 2016 31 Mar 2016
Q4 2015 -47% -6.1% -15% 01 Oct 2015 31 Dec 2015
Q3 2015 -45% 01 Jul 2015 30 Sep 2015
Q2 2015 -41% 01 Apr 2015 30 Jun 2015
Q1 2015 -40% 01 Jan 2015 31 Mar 2015
Q4 2014 -41% 01 Oct 2014 31 Dec 2014

Karyopharm Therapeutics Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2025 -179% -140% -353% 01 Jan 2025 31 Dec 2025
2024 -40% +11% +22% 01 Jan 2024 31 Dec 2024
2023 -50% +7.5% +13% 01 Jan 2023 31 Dec 2023
2022 -58% -14% -31% 01 Jan 2022 31 Dec 2022
2021 -44% +10% +18% 01 Jan 2021 31 Dec 2021
2020 -54% +17% +24% 01 Jan 2020 31 Dec 2020
2019 -71% +2.6% +3.5% 01 Jan 2019 31 Dec 2019
2018 -74% +1.3% +1.7% 01 Jan 2018 31 Dec 2018
2017 -75% -15% -25% 01 Jan 2017 31 Dec 2017
2016 -60% -13% -29% 01 Jan 2016 31 Dec 2016
2015 -47% -6.1% -15% 01 Jan 2015 31 Dec 2015
2014 -41% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.